Common drug may shield kidneys from dye damage in ICU
NCT ID NCT07561801
First seen May 14, 2026 · Last updated May 24, 2026 · Updated 2 times
Summary
This study looked at whether pentoxifylline, a drug that improves blood flow, could prevent kidney injury caused by contrast dye used in medical imaging. Researchers studied 70 adults with chronic kidney disease in the intensive care unit who needed dye for procedures like heart catheterization. The goal was to see if the drug reduced the number of patients who developed contrast-induced nephropathy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRAST-INDUCED NEPHROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tanta University
Tanta, El-Gharbia, 31527, Egypt
Conditions
Explore the condition pages connected to this study.